Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Posttraumatic Symptoms in IDF Soldiers Using Attention Bias Modification (ABM): A Randomized Controlled Trial
Brief Summary: Military deployment to combat zones involves exposure to trauma at a higher than average rate and therefore presents a unique opportunity to study predisposing factors to posttraumatic stress reactions and test strategies designed to prevent and ameliorate posttraumatic symptoms. Decades of scientific research on the origins of resilience and vulnerability to combat-related posttraumatic stress symptoms revealed various predisposing and protective factors. All these factors however, offer limited opportunity for systematic pre-deployment prevention efforts. Considering the magnitude of psychological adjustment difficulties encountered by combat personnel in deployment and the limited access to existing evidence-based therapies for PTSD, the development and testing of a novel evidence-based and theory-driven prevention protocol for these problems is of considerable significance. The current study translates cognitive-neuroscience knowledge and attention bias modification research into a novel computerized training tool that could be easily delivered to soldiers during different stages of the deployment cycle. If proved efficacious in reducing risk for posttraumatic symptoms ABMT could be integrated into the Army's resilience training program. Thus, we propose a longitudinal double-blind randomized controlled study of ABMT in soldiers. We will assess attention bias and symptoms before deployment, will randomly assign soldiers to either 8 ABMT sessions, 4 ABMT sessions, 8 Placebo training sessions, or no training. Following 6 months of deployment to combat zone symptoms will be assessed again.


Options:
A: Arm Label: Group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Manualized Therapy | Arm Label: Control Group; Type: OTHER; Interventions: Behavioral: Control Group | Intervention Type: BEHAVIORAL; Name: Manualized Therapy; Assigned to Arm(s): Group therapy | Intervention Type: BEHAVIORAL; Name: Control Group; Assigned to Arm(s): Control Group
B: Arm Label: Resiliency Training; Type: EXPERIMENTAL; Interventions: Behavioral: Disaster Worker Resiliency Training | Arm Label: Waitlist; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Disaster Worker Resiliency Training; Assigned to Arm(s): Resiliency Training
C: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: ACTr (Acceptance and Commitment Training) | Arm Label: Wait-list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ACTr (Acceptance and Commitment Training); Assigned to Arm(s): Intervention Group
D: Arm Label: Active ABMT8; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active ABMT8 | Arm Label: Active ABMT4; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active ABMT4 | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo | Intervention Type: BEHAVIORAL; Name: Active ABMT8; Assigned to Arm(s): Active ABMT8 | Intervention Type: BEHAVIORAL; Name: Active ABMT4; Assigned to Arm(s): Active ABMT4 | Intervention Type: BEHAVIORAL; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D